546 related articles for article (PubMed ID: 15641774)
1. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
Paula S; Tabet MR; Ball WJ
Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
[TBL] [Abstract][Full Text] [Related]
2. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
Cornelius F; Mahmmoud YA
Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
Paula S; Monson N; Ball WJ
Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
[TBL] [Abstract][Full Text] [Related]
5. Identification of a model cardiac glycoside receptor: comparisons with Na+,K+-ATPase.
Kasturi R; Yuan J; McLean LR; Margolies MN; Ball WJ
Biochemistry; 1998 May; 37(19):6658-66. PubMed ID: 9578549
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding sites of Na,K-ATPase.
Lingrel JB; Croyle ML; Woo AL; Argüello JM
Acta Physiol Scand Suppl; 1998 Aug; 643():69-77. PubMed ID: 9789548
[TBL] [Abstract][Full Text] [Related]
8. Progesterone derivatives that bind to the digitalis receptor: effects on Na+,K+-ATPase and isolated tissues.
LaBella FS; Bihler I; Templeton J; Kim RS; Hnatowich M; Rohrer D
Fed Proc; 1985 Sep; 44(12):2806-11. PubMed ID: 2411607
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies of the Na,K-ATPase.
Lingrel JB; Van Huysse J; O'Brien W; Jewell-Motz E; Askew R; Schultheis P
Kidney Int Suppl; 1994 Jan; 44():S32-9. PubMed ID: 8127032
[TBL] [Abstract][Full Text] [Related]
10. Na+, K+-ATPase of the canine mesenteric artery.
Wallick ET; Adams RJ; Fondacaro JD; Jacobson ED
Fed Proc; 1982 Apr; 41(6):2101-5. PubMed ID: 6281071
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions.
Breier A; Vrbanová A; Docolomanský P; Bohácová V; Ziegelhöffer A
Gen Physiol Biophys; 1996 Aug; 15(4):291-307. PubMed ID: 9088927
[TBL] [Abstract][Full Text] [Related]
12. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity.
Carfagna MA; Muhoberac BB
Mol Pharmacol; 1993 Jul; 44(1):129-41. PubMed ID: 8393517
[TBL] [Abstract][Full Text] [Related]
13. [Effect of mineralocorticoid analogs on Na(+),K(+)-dependent ATPase].
Kamernitskiĭ AV; Smolenskiĭ EA; Makeev GM; Vesela II; Mirsalikhova NM; Turuta AM; Zefirov NS
Bioorg Khim; 2002; 28(3):269-76. PubMed ID: 12077854
[TBL] [Abstract][Full Text] [Related]
14. Na+,K+-ATPase: structure, mechanism, and regulation.
Lopina OD
Membr Cell Biol; 2000; 13(6):721-44. PubMed ID: 10963432
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
16. Active compounds in Chinese herbs and medicinal animal products which promote blood circulation via inhibition of Na+, K+-ATPase.
Tzen JT; Chen RJ; Chung TY; Chen YC; Lin NH
Chang Gung Med J; 2010; 33(2):126-36. PubMed ID: 20438664
[TBL] [Abstract][Full Text] [Related]
17. Novel analogues of Istaroxime, a potent inhibitor of Na(+),K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold.
Gobbini M; Armaroli S; Banfi L; Benicchio A; Carzana G; Ferrari P; Giacalone G; Marazzi G; Moro B; Micheletti R; Sputore S; Torri M; Zappavigna MP; Cerri A
Bioorg Med Chem; 2010 Jun; 18(12):4275-99. PubMed ID: 20494582
[TBL] [Abstract][Full Text] [Related]
18. [Concepts of the oligomeric structure and function of Na, K-ATPase based on the results of studying ligand binding and of determining the size of the molecular target].
Norby JG
Nauchnye Doki Vyss Shkoly Biol Nauki; 1990; (6):120-31. PubMed ID: 2169909
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of the Na+, K+-ATPase digitalis binding site.
Keenan SM; DeLisle RK; Welsh WJ; Paula S; Ball WJ
J Mol Graph Model; 2005 Jun; 23(6):465-75. PubMed ID: 15886034
[TBL] [Abstract][Full Text] [Related]
20. Cryptosin induces backbone structural changes in cardiac Na+ and K+ dependent adenosinetriphosphatase.
Venkateswara RR; Dipak D; Banning JW; Vaidyanathan CS
Biochem Int; 1990 Oct; 22(2):287-94. PubMed ID: 1965277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
